Clinical Trials for Clexio Biosciences

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Clexio Biosciences

Clinical Trials (1)

NCT06340958
A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder
PHASE2Active, not recruiting
90 participants
Started: Mar 18, 2024 · Completed: Jan 10, 2026
1 condition1 sponsor23 locations